摘要
目前,癌症是世界范围内主要的死亡原因。恶性肿瘤是一类以细胞生长失控为特征的疾病,最终侵入其他组织并继发。其他部位的恶性生长是由转移引起的。细胞间通讯在癌症中起着重要的作用,尤其是在细胞增殖和协调过程中,进而导致了肿瘤的发生。MOR侵袭、转移及耐药性的发展。细胞之间以多种方式相互沟通,即:(一)通过与相邻细胞的间隙连接;(二)通过具有近距离的外小体。(3)通过化学信使与遥远的细胞。此外,在细胞间组分转移的情况下,隧道纳米管(Tnt)的细胞-细胞连接正变得越来越重要。细胞间的ED。一般来说,细胞器,如高尔基囊泡和线粒体,以及生物大分子,如核酸和蛋白质,都是通过这些TNT传递的。这些TNT是长细胞质e。x张力是由肌动蛋白组成,作为细胞间的桥梁,连接多种细胞类型。恶性细胞与其他恶性细胞或周围肿瘤细胞形成TNT。矩阵。这些TNT有助于肿瘤的形成、组织和传播过程。本文主要对tnt介导的细胞信号转导在癌性micror中的作用作一综述。O-环境。抑制TNT形成的药物,如二甲双胍和艾氏菌素,可用于治疗肿瘤的生长、增殖、肿瘤的侵袭和转移。
关键词: 隧道纳米管、肿瘤、转移、细胞增殖、TNT、微环境。
图形摘要
Current Cancer Drug Targets
Title:Tunneling Nanotubes: A Versatile Target for Cancer Therapy
Volume: 18 Issue: 6
关键词: 隧道纳米管、肿瘤、转移、细胞增殖、TNT、微环境。
摘要: Currently Cancer is the leading cause of death worldwide. Malignancy or cancer is a class of diseases characterized by uncontrolled cell growth that eventually invade other tissues and develop secondary malignant growth at other sites by metastasis. Intercellular communication plays a major role in cancer, particularly in the process of cell proliferation and coordination which in turn leads to tumor invasion, metastasis and development of resistance to therapy. Cells communicate among themselves in a variety of ways, namely: i) via gap junctions with adjacent cells; ii) via exosomes with nearby cells; and iii) via chemical messengers with distant cells. Besides, cell - cell connection by tunneling nanotubes (TnTs) is recently gaining importance where intercellular components are transferred between cells. In general cell organelles like Golgi vesicle and mitochondria; and biomolecules like nucleic acids and proteins are transferred through these TnTs. These TnTs are long cytoplasmic extensions made up of actin that function as intercellular bridge and connect a wide variety of cell types. Malignant cells form TnTs with either other malignant cells or cells of the surrounding tumor matrix. These TnTs help in the process of initiation of tumor formation, its organization and propagation. The current review focuses on the role of TnTs mediated cell – cell signaling in cancer micro-environment. Drugs that inhibit TnT-formation such as metformin and everolimus can be targeted towards TnTs in the management of cancer growth, proliferation, tumor invasion and metastasis.
Export Options
About this article
Cite this article as:
Tunneling Nanotubes: A Versatile Target for Cancer Therapy, Current Cancer Drug Targets 2018; 18 (6) . https://dx.doi.org/10.2174/1568009618666171129222637
DOI https://dx.doi.org/10.2174/1568009618666171129222637 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Heparan Sulfate Proteoglycans, Tumour Progression and the Cancer Stem Cell Niche
Current Cancer Therapy Reviews Synthesis and Biological Interest of Structured Docosahexaenoic Acid–Containing Triacylglycerols and Phospholipids
Current Organic Chemistry Improving Protein Stability and Controlling Protein Release by Adding Poly (Cyclohexane -1, 4 -Diyl Acetone Dimethylene Ketal) to PLGA Microspheres
Current Drug Delivery B Cell Modulation Strategies in Autoimmunity: The SLE Example
Current Pharmaceutical Design Recent Advances in Antiangiogenic Agents with VEGFR as Target
Mini-Reviews in Medicinal Chemistry In-silico Designing of Novel Camptothecin Analogues as Potent Inhibitors of Topoisomerase I: A Molecular Docking, QSAR, and ADME-T Study
Letters in Drug Design & Discovery Targeting the ERK Pathway: Novel Therapeutics for Thyroid Cancer
Current Drug Targets - Immune, Endocrine & Metabolic Disorders New and Highly Potent Antitumor Natural Products from Marine-Derived Fungi: Covering the Period from 2003 to 2012
Current Topics in Medicinal Chemistry Research Progress of Exogenous Plant MiRNAs in Cross-Kingdom Regulation
Current Bioinformatics Prediction of Chemical Multi-target Profiles and Adverse Outcomes with Systems Toxicology
Current Medicinal Chemistry Recent Advances in Protein and Peptide Drug Delivery: A Special Emphasis on Polymeric Nanoparticles
Protein & Peptide Letters Synergism from Combination of Cisplatin and Multicentred Platinums Coded as DH6Cl and TH1 in the Human Ovarian Tumour Models
Medicinal Chemistry Inhibition of Human 5-Lipoxygenase and Anti-Neoplastic Effects by 2-Amino-1,4-Benzoquinones
Medicinal Chemistry Stimuli-responsive Carriers for Controlled Intracellular Drug Release
Current Medicinal Chemistry Network Systems Underlying Traditional Chinese Medicine Syndrome and Herb Formula
Current Bioinformatics Comparative Study on Photodynamic Activation of Ortho-Toluidine Blue and Methylene Blue Loaded Mesoporous Silica Nanoparticles Against Resistant Microorganisms
Recent Patents on Drug Delivery & Formulation Genistein Affects Expression of Cytochrome P450 (CYP450) Genes in Hepatocellular Carcinoma (HEPG2/C3A) Cell Line
Drug Metabolism Letters Lyn Regulates Cytotoxicity in Respiratory Epithelial Cells Challenged by Cigarette Smoke Extracts
Current Molecular Medicine The Complex Dynamics of Breast Cancer
Current Women`s Health Reviews Oxidative Stress Based-Biomarkers in Oral Carcinogenesis: How Far Have We Gone?
Current Molecular Medicine